Free Newsletter
FEATURES >> The most interesting logos in Pharma
Would-be whistleblower sues Bayer over firing
Pharma whistleblowers aren't just focused on alleged marketing shenanigans. Arcane accounting rules gets attention too. This time, the company is Bayer, and the whistleblower raised the red flag over compliance with the very complicated Sarbanes-Oxley Act.
In a federal lawsuit, plaintiff Ralph Fabiano claims that a senior Bayer executive told him to falsify the results of certain auditing and accounting tests, and he refused. After refusing repeatedly, he was fired, the suit alleges. And that act would be a violation of the Sarbanes-Oxley law's whistleblower provisions.
Bayer says that the U.S. Department of Labor had investigated Fabiano's claims, and cleared the company of wrongdoing in a June 17 letter. "Consistent with our company policy we do not comment on matters of active litigation; however, we will defend ourselves vigorously in this case," Bryan Iams, a Bayer spokesman, tells Reuters.
- read the Reuters story
Related Articles:
Bayer - Big Pharma's Q2 2010 Earnings Report
Grassley zeroes in on pharma whistleblowers
Ruling could prevent whistleblower suits
NEJM: Wherefore art thou whistleblowers?
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities



SHARE
WITH: